Patents by Inventor Kenneth A. Pass

Kenneth A. Pass has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140080147
    Abstract: The present invention relates to novel CD3 epsilon peptides, antibodies against the novel CD3 epsilon peptides. The invention also relates to methods of identifying an immunodeficiency (such as severe combined immunodeficiency (SCID) or a T cell immunodeficiency) in a patient, which may involve antibodies against CD3 epsilon peptides.
    Type: Application
    Filed: August 16, 2013
    Publication date: March 20, 2014
    Applicant: Health Research, Inc.
    Inventors: Kenneth A. Pass, Barbara Lindau-Shepard, David K. Janik
  • Patent number: 8569450
    Abstract: The present invention relates to novel CD3 epsilon peptides, antibodies against the novel CD3 epsilon peptides. The invention also relates to methods of identifying an immunodeficiency (such as severe combined immunodeficiency (SCID) or a T cell immunodeficiency) in a patient, which may involve antibodies against CD3 epsilon peptides.
    Type: Grant
    Filed: March 3, 2011
    Date of Patent: October 29, 2013
    Assignee: Health Research Inc.
    Inventors: Kenneth A. Pass, Barbara Lindau-Shepard, David K. Janik
  • Publication number: 20110217790
    Abstract: The present invention relates to novel CD3 epsilon peptides, antibodies against the novel CD3 epsilon peptides. The invention also relates to methods of identifying an immunodeficiency (such as severe combined immunodeficiency (SCID) or a T cell immunodeficiency) in a patient, which may involve antibodies against CD3 epsilon peptides.
    Type: Application
    Filed: March 3, 2011
    Publication date: September 8, 2011
    Inventors: Kenneth A. Pass, Barbara Lindau-Shepard, David K. Janik
  • Publication number: 20110159530
    Abstract: Methods are provided for simultaneously measuring hematocrit (hct) level and the concentration of a biomarker in a blood specimen. Thus, serum biomarker concentrations can be more accurately measured. The methods are particularly useful for newborn screening programs.
    Type: Application
    Filed: June 10, 2009
    Publication date: June 30, 2011
    Inventors: Kenneth A. Pass, Martin Sorette, Barbara Shepard
  • Publication number: 20100068729
    Abstract: Provided are methods for the detection and diagnosis of a predisposition for developing diabetes. The methods are based on the discovery that abnormal levels of the selected analyte in biological samples, typically blood samples, of patients who are at risk are supportive of a diagnosis of a predisposition for developing diabetes. At least one new biomarker for a predisposition for diabetes is thus disclosed, IGF-1. Other important biomarkers for diabetes are described, including but not limited to ZAG, clusterin, corticosteroid-binding globulin, lumican, and serotransferrin. Kits containing reagents to assist in the analysis of biological samples are also described.
    Type: Application
    Filed: September 9, 2009
    Publication date: March 18, 2010
    Inventors: Samuel T. LABRIE, Michael D. Spain, James P. Mapes, Ralph L. McDade, Kenneth A. Pass